Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IKBKB | O14920 | 1/20 | 0.52 |
| ▸ | CHUK | O15111 | 1/20 | 0.52 |
| ▸ | DAPK3 | O43293 | 1/20 | 0.52 |
| ▸ | JAK2 | O60674 | 1/20 | 0.52 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.52 |
| ▸ | MAP4K4 | O95819 | 1/20 | 0.52 |
| ▸ | PAK4 | O96013 | 1/20 | 0.52 |
| ▸ | CSF1R | P07333 | 1/20 | 0.52 |
| ▸ | RET | P07949 | 1/20 | 0.52 |
| ▸ | IGF1R | P08069 | 1/20 | 0.52 |
| ▸ | FGFR1 | P11362 | 1/20 | 0.52 |
| ▸ | PRKACA | P17612 | 1/20 | 0.52 |
| ▸ | FLT1 | P17948 | 1/20 | 0.52 |
| ▸ | LTK | P29376 | 1/20 | 0.52 |
| ▸ | GRK5 | P34947 | 1/20 | 0.52 |
| ▸ | KDR | P35968 | 1/20 | 0.52 |
| ▸ | MAP2K2 | P36507 | 1/20 | 0.52 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.52 |
| ▸ | CSNK1A1 | P48729 | 1/20 | 0.52 |
| ▸ | CDK8 | P49336 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28868 | 0.98 | IKBKB (0.53) | IKBKBCHUKDAPK3JAK2PRKD3 | |
| SCHEMBL28859500 | 0.98 | IKBKB (0.53) | IKBKBCHUKDAPK3JAK2PRKD3 | |
| Benzene SCHEMBL28095234 | 0.98 | IKBKB (0.53) | IKBKBCHUKDAPK3JAK2PRKD3 | |
| Hydrochloric Acid SCHEMBL8685286 | 0.96 | IKBKB (0.52) | IKBKBCHUKDAPK3JAK2PRKD3 | |
| SCHEMBL9448814 | 0.96 | IKBKB (0.52) | IKBKBCHUKDAPK3JAK2PRKD3 | |
| Hydrochloric Acid SCHEMBL1238416 | 0.96 | IKBKB (0.52) | IKBKBCHUKDAPK3JAK2PRKD3 | |
| Hydrochloric Acid SCHEMBL5385347 | 0.96 | IKBKB (0.52) | IKBKBCHUKDAPK3JAK2PRKD3 | |
| Hydrochloric Acid SCHEMBL21643628 | 0.96 | IKBKB (0.52) | IKBKBCHUKDAPK3JAK2PRKD3 | |
| Hydrochloric Acid SCHEMBL17396321 | 0.96 | IKBKB (0.52) | IKBKBCHUKDAPK3JAK2PRKD3 | |
| SCHEMBL2879644 | 0.96 | IKBKB (0.52) | IKBKBCHUKDAPK3JAK2PRKD3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10662210-B2 | Compositions and methods comprising osmium for the treatment of cancers | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2020-05-26 | — | — | US | disclosed |
| US-20190276484-A1 | COMPOSITIONS AND METHODS COMPRISING OSMIUM FOR THE TREATMENT OF CANCERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2019-09-12 | — | — | US | disclosed |
| US-20170233422-A1 | COMPOSITIONS AND METHODS COMPRISING OSMIUM FOR THE TREATMENT OF CANCERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2017-08-17 | — | — | US | disclosed |
| WO-2016004156-A1 | COMPOSITIONS AND METHODS COMPRISING OSMIUM FOR TREATMENT OF CANCERS | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2016-01-07 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10662210-B2 | Compositions and methods comprising osmium for the treatment of cancers | OGFR, OTC, EGFR | IKBKB 4280/4885CHUK 4156/4885DAPK3 1013/4885 |
| US-20190276484-A1 | COMPOSITIONS AND METHODS COMPRISING OSMIUM FOR THE TREATMENT OF CANCERS | OGFR, OTC, EGFR | IKBKB 4280/4885CHUK 4156/4885DAPK3 1013/4885 |
| US-20170233422-A1 | COMPOSITIONS AND METHODS COMPRISING OSMIUM FOR THE TREATMENT OF CANCERS | OGFR, OTC, EGFR | IKBKB 4280/4885CHUK 4156/4885DAPK3 1013/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.